{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:11:18Z","timestamp":1788858678284,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007686","name":"Instituto Nacional de Perinatolog\u00eda","doi-asserted-by":"publisher","award":["INPER-2024-1-19"],"award-info":[{"award-number":["INPER-2024-1-19"]}],"id":[{"id":"10.13039\/501100007686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Direcci\u00f3n General de Politicas en investigacion en salud","award":["FPIS2024-INPER-6393"],"award-info":[{"award-number":["FPIS2024-INPER-6393"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00705-026-06706-1","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:17:20Z","timestamp":1786094240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiviral efficacy of Trappin-2\/Elafin against Zika virus in the human keratinocyte HaCaT cell line"],"prefix":"10.1007","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4430-8886","authenticated-orcid":false,"given":"V\u00edctor Javier","family":"Cruz-Holgu\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Ulloa-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0733-5172","authenticated-orcid":false,"given":"Roc\u00edo Yazmin","family":"Ben\u00edtez-Zeferino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4214-2735","authenticated-orcid":false,"given":"Luis","family":"Herrera- Moro Hiutron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6715-9671","authenticated-orcid":false,"given":"Addy Cecilia","family":"Helguera-Repetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-6260","authenticated-orcid":false,"given":"Luis Adri\u00e1n","family":"de Jes\u00fas-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0291-2620","authenticated-orcid":false,"given":"Guadalupe","family":"Le\u00f3n-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-8591","authenticated-orcid":false,"given":"Julio","family":"Garcia-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-0360","authenticated-orcid":false,"given":"Sergio","family":"Aguilar-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-2545","authenticated-orcid":false,"given":"Nicolas","family":"Villegas-Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2642-3872","authenticated-orcid":false,"given":"Leticia","family":"Cedillo-Barr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5726-5953","authenticated-orcid":false,"given":"Mois\u00e9s","family":"Le\u00f3n-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"6706_CR1","doi-asserted-by":"publisher","first-page":"e12616","DOI":"10.1111\/aji.12616","volume":"77","author":"NS de Carvalho","year":"2017","unstructured":"de Carvalho NS, de Carvalho BF, D\u00f3ris B et al (2017) Zika virus and pregnancy: An overview. Am J Reprod Immunol 77:e12616. https:\/\/doi.org\/10.1111\/aji.12616","journal-title":"Am J Reprod Immunol"},{"key":"6706_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1055\/s-0036-1580089","volume":"33","author":"C Marrs","year":"2016","unstructured":"Marrs C, Olson G, Saade G et al (2016) Zika Virus and Pregnancy: A Review of the Literature and Clinical Considerations. Am J Perinatol 33:625\u2013639. https:\/\/doi.org\/10.1055\/s-0036-1580089","journal-title":"Am J Perinatol"},{"key":"6706_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/pd.5446","volume":"39","author":"L Pomar","year":"2019","unstructured":"Pomar L, Musso D, Malinger G et al (2019) Zika virus during pregnancy: From maternal exposure to congenital Zika virus syndrome. Prenat Diagn 39:420\u2013430. https:\/\/doi.org\/10.1002\/pd.5446","journal-title":"Prenat Diagn"},{"key":"6706_CR4","doi-asserted-by":"publisher","first-page":"i1049","DOI":"10.1136\/bmj.i1049","volume":"352","author":"M Basarab","year":"2016","unstructured":"Basarab M, Bowman C, Aarons EJ, Cropley I (2016) Zika virus. BMJ 352:i1049. https:\/\/doi.org\/10.1136\/bmj.i1049","journal-title":"BMJ"},{"key":"6706_CR5","doi-asserted-by":"publisher","unstructured":"Sampathkumar P, Sanchez JL (2016) Zika virus in the Americas: a review for clinicians. Mayo Clinic Proc 91:514\u2013521. https:\/\/doi.org\/10.1016\/j.mayocp.2016.02.017","DOI":"10.1016\/j.mayocp.2016.02.017"},{"key":"6706_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.autrev.2016.03.020","volume":"15","author":"G Lucchese","year":"2016","unstructured":"Lucchese G, Kanduc D (2016) Zika virus and autoimmunity: From microcephaly to Guillain-Barr\u00e9 syndrome, and beyond. Autoimmun rev 15:801\u2013808. https:\/\/doi.org\/10.1016\/j.autrev.2016.03.020","journal-title":"Autoimmun rev"},{"key":"6706_CR7","doi-asserted-by":"publisher","first-page":"e1006004","DOI":"10.1371\/journal.ppat.1006004","volume":"12","author":"M Manangeeswaran","year":"2016","unstructured":"Manangeeswaran M, Ireland DDC, Verthelyi D (2016) Zika (PRVABC59) Infection Is Associated with T cell Infiltration and Neurodegeneration in CNS of Immunocompetent Neonatal C57Bl\/6 Mice. PLoS Pathog 12:e1006004. https:\/\/doi.org\/10.1371\/journal.ppat.1006004","journal-title":"PLoS Pathog"},{"key":"6706_CR8","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/glia.24353","volume":"71","author":"A Quincozes-Santos","year":"2023","unstructured":"Quincozes-Santos A, Bobermin LD, Costa NLF et al (2023) The role of glial cells in Zika virus-induced neurodegeneration. Glia 71:1791\u20131803. https:\/\/doi.org\/10.1002\/glia.24353","journal-title":"Glia"},{"key":"6706_CR9","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0140-6736(17)31450-2","volume":"390","author":"D Baud","year":"2017","unstructured":"Baud D, Gubler DJ, Schaub B et al (2017) An update on Zika virus infection. Lancet 390:2099\u20132109. https:\/\/doi.org\/10.1016\/S0140-6736(17)31450-2","journal-title":"Lancet"},{"key":"6706_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/cmr.00072-15","volume":"29","author":"D Musso","year":"2016","unstructured":"Musso D, Gubler DJ (2016) Zika Virus. Clin Microbiol Rev 29:487\u2013524. https:\/\/doi.org\/10.1128\/cmr.00072-15","journal-title":"Clin Microbiol Rev"},{"key":"6706_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3201\/eid2207.151990","volume":"22","author":"AR Plourde","year":"2016","unstructured":"Plourde AR, Bloch EM (2016) A Literature Review of Zika Virus. Emerg Infect Dis 22:1185\u20131192. https:\/\/doi.org\/10.3201\/eid2207.151990","journal-title":"Emerg Infect Dis"},{"key":"6706_CR12","doi-asserted-by":"publisher","unstructured":"Castanha PMS, Azar SR, Yeung J et al (2024) Aedes aegypti mosquito probing enhances dengue virus infection of resident myeloid cells in human skin. Viruses 16. https:\/\/doi.org\/10.3390\/v16081253","DOI":"10.3390\/v16081253"},{"key":"6706_CR13","first-page":"139","volume-title":"Update on Orthoflavivirus - Understanding Orthoflavivirus","author":"JC Corzo-G\u00f3mez","year":"2025","unstructured":"Corzo-G\u00f3mez JC, Montecillo-Aguado M, Mart\u00ednez-Molina EC et al (2025) Update on Vertical Transmission and Coinfection of Zika and Dengue Viruses in Aedes aegypti and Research on Botanical Extracts as Alternative Vector Control Strategies. Update on Orthoflavivirus - Understanding Orthoflavivirus. Potential Reemerging Pathogens, IntechOpen"},{"key":"6706_CR14","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1128\/jvi.00354-15","volume":"89","author":"R Hamel","year":"2015","unstructured":"Hamel R, Dejarnac O, Wichit S et al (2015) Biology of Zika Virus Infection in Human Skin Cells. J Virol 89:8880\u20138896. https:\/\/doi.org\/10.1128\/jvi.00354-15","journal-title":"J Virol"},{"key":"6706_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","volume":"36","author":"AE Ngono","year":"2018","unstructured":"Ngono AE, Shresta S (2018) Immune Response to Dengue and Zika. Annu Rev Immunol 36:279\u2013308. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053142","journal-title":"Annu Rev Immunol"},{"key":"6706_CR16","doi-asserted-by":"publisher","unstructured":"Rodrigues de Sousa J, Azevedo R do S, da S, Quaresma JAS, Vasconcelos PF da C (2021) The innate immune response in Zika virus infection. Rev Med Virol 31:e2166. https:\/\/doi.org\/10.1002\/rmv.2166","DOI":"10.1002\/rmv.2166"},{"key":"6706_CR17","doi-asserted-by":"publisher","unstructured":"Sekaran SD, Ismail AA, Thergarajan G et al (2022) Host immune response against DENV and ZIKV infections. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.975222","DOI":"10.3389\/fcimb.2022.975222"},{"key":"6706_CR18","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/ph6121543","volume":"6","author":"AA Bahar","year":"2013","unstructured":"Bahar AA, Ren D, Bahar AA, Ren D (2013) Antimicrobial Peptides. Pharmaceuticals 6:1543\u20131575. https:\/\/doi.org\/10.3390\/ph6121543","journal-title":"Pharmaceuticals"},{"key":"6706_CR19","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10529-005-0936-5","volume":"27","author":"K De Smet","year":"2005","unstructured":"De Smet K, Contreras R (2005) Human Antimicrobial Peptides: Defensins, Cathelicidins and Histatins. Biotechnol Lett 27:1337\u20131347. https:\/\/doi.org\/10.1007\/s10529-005-0936-5","journal-title":"Biotechnol Lett"},{"key":"6706_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/ph7050545","volume":"7","author":"G Wang","year":"2014","unstructured":"Wang G (2014) Human Antimicrobial Peptides and Proteins. Pharmaceuticals 7:545\u2013594. https:\/\/doi.org\/10.3390\/ph7050545","journal-title":"Pharmaceuticals"},{"key":"6706_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/biof.1225","volume":"41","author":"K Bandurska","year":"2015","unstructured":"Bandurska K, Berdowska A, Barczy\u0144ska-Felusiak R, Krupa P (2015) Unique features of human cathelicidin LL-37. BioFactors 41:289\u2013300. https:\/\/doi.org\/10.1002\/biof.1225","journal-title":"BioFactors"},{"key":"6706_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000446282","volume":"59","author":"JI Casta\u00f1eda-S\u00e1nchez","year":"2016","unstructured":"Casta\u00f1eda-S\u00e1nchez JI, Dom\u00ednguez-Mart\u00ednez DA, Olivar-Espinosa N et al (2016) Expression of Antimicrobial Peptides in Human Monocytic Cells and Neutrophils in Response to Dengue Virus Type 2. Intervirology 59:8\u201319. https:\/\/doi.org\/10.1159\/000446282","journal-title":"Intervirology"},{"key":"6706_CR23","doi-asserted-by":"publisher","first-page":"102016","DOI":"10.1016\/j.jddst.2020.102016","volume":"60","author":"X Lin","year":"2020","unstructured":"Lin X, Wang R, Mai S (2020) Advances in delivery systems for the therapeutic application of LL37. J Drug Deliv Sci Technol 60:102016. https:\/\/doi.org\/10.1016\/j.jddst.2020.102016","journal-title":"J Drug Deliv Sci Technol"},{"key":"6706_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1046\/j.1523-1747.2003.12043.x","volume":"120","author":"A Pol","year":"2003","unstructured":"Pol A, Pfundt R, Zeeuwen P et al (2003) Transcriptional Regulation of the Elafin Gene in Human Keratinocytes. J Invest Dermatology 120:301\u2013307. https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12043.x","journal-title":"J Invest Dermatology"},{"key":"6706_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00042737-200606000-00007","volume":"18","author":"J Schauber","year":"2006","unstructured":"Schauber J, Rieger D, Weiler F et al (2006) Heterogeneous expression of human cathelicidin hCAP18\/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 18:615","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6706_CR26","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.biocel.2012.05.007","volume":"44","author":"T Verrier","year":"2012","unstructured":"Verrier T, Solhonne B, Sallenave J-M, Garcia-Verdugo I (2012) The WAP protein Trappin-2\/Elafin: A handyman in the regulation of inflammatory and immune responses. Int J Biochem Cell Biol 44:1377\u20131380. https:\/\/doi.org\/10.1016\/j.biocel.2012.05.007","journal-title":"Int J Biochem Cell Biol"},{"key":"6706_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jsbmb.2010.03.034","volume":"121","author":"JH White","year":"2010","unstructured":"White JH (2010) Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future. J Steroid Biochem Mol Biol 121:234\u2013238. https:\/\/doi.org\/10.1016\/j.jsbmb.2010.03.034","journal-title":"J Steroid Biochem Mol Biol"},{"key":"6706_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1128\/iai.70.2.953-963.2002","volume":"70","author":"K Hase","year":"2002","unstructured":"Hase K, Eckmann L, Leopard JD et al (2002) Cell Differentiation Is a Key Determinant of Cathelicidin LL-37\/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium. Infect Immun 70:953\u2013963. https:\/\/doi.org\/10.1128\/iai.70.2.953-963.2002","journal-title":"Infect Immun"},{"key":"6706_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.placenta.2006.01.006","volume":"28","author":"AE King","year":"2007","unstructured":"King AE, Paltoo A, Kelly RW et al (2007) Expression of Natural Antimicrobials by Human Placenta and Fetal Membranes. Placenta 28:161\u2013169. https:\/\/doi.org\/10.1016\/j.placenta.2006.01.006","journal-title":"Placenta"},{"key":"6706_CR30","doi-asserted-by":"publisher","first-page":"e52738","DOI":"10.1371\/journal.pone.0052738","volume":"7","author":"AG Drannik","year":"2012","unstructured":"Drannik AG, Nag K, Yao X-D et al (2012) Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells. PLoS ONE 7:e52738. https:\/\/doi.org\/10.1371\/journal.pone.0052738","journal-title":"PLoS ONE"},{"key":"6706_CR31","doi-asserted-by":"publisher","first-page":"15610","DOI":"10.1021\/bi051418i","volume":"44","author":"N Guyot","year":"2005","unstructured":"Guyot N, Zani M-L, Maurel M-C et al (2005) Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase. Biochemistry 44:15610\u201315618. https:\/\/doi.org\/10.1021\/bi051418i","journal-title":"Biochemistry"},{"key":"6706_CR32","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1128\/JVI.02243-12","volume":"87","author":"AG Drannik","year":"2013","unstructured":"Drannik AG, Nag K, Sallenave J-M, Rosenthal KL (2013) Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes. J Virol 87:7526\u20137538. https:\/\/doi.org\/10.1128\/JVI.02243-12","journal-title":"J Virol"},{"key":"6706_CR33","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1172\/JCI5099","volume":"103","author":"SH Zaidi","year":"1999","unstructured":"Zaidi SH, Hui CC, Cheah AY et al (1999) Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis. J Clin Invest 103:1211\u20131219. https:\/\/doi.org\/10.1172\/JCI5099","journal-title":"J Clin Invest"},{"key":"6706_CR34","doi-asserted-by":"publisher","unstructured":"Chessa C, Bodet C, Jousselin C et al (2022) Antiviral effect of hBD-3 and LL-37 during human primary keratinocyte infection with West Nile virus. Viruses 14. https:\/\/doi.org\/10.3390\/v14071552","DOI":"10.3390\/v14071552"},{"key":"6706_CR35","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.imbio.2018.07.006","volume":"223","author":"M L\u00f3pez-Gonz\u00e1lez","year":"2018","unstructured":"L\u00f3pez-Gonz\u00e1lez M, Meza-S\u00e1nchez D, Garc\u00eda-Cordero J et al (2018) Human keratinocyte cultures (HaCaT) can be infected by DENV, triggering innate immune responses that include IFN\u03bb and LL37. Immunobiology 223:608\u2013617. https:\/\/doi.org\/10.1016\/j.imbio.2018.07.006","journal-title":"Immunobiology"},{"key":"6706_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pep.2019.05.005","volume":"162","author":"J Corzo-G\u00f3mez","year":"2019","unstructured":"Corzo-G\u00f3mez J, Garc\u00eda-Cordero J, Montes G\u00f3mez AE et al (2019) Expression and purification of domain III proteins from Dengue and Zika viruses. Protein Exp Purif 162:38\u201343. https:\/\/doi.org\/10.1016\/j.pep.2019.05.005","journal-title":"Protein Exp Purif"},{"key":"6706_CR37","doi-asserted-by":"publisher","first-page":"e00750","DOI":"10.1128\/genomeA.00750-16","volume":"4","author":"JA D\u00edaz-Qui\u00f1onez","year":"2016","unstructured":"D\u00edaz-Qui\u00f1onez JA, Pe\u00f1a-Alonso R, Mendieta-Condado E et al (2016) Complete Genome Sequence of Zika Virus Isolated in Mexico, 2016. Genome Announc 4:e00750\u2013e00716. https:\/\/doi.org\/10.1128\/genomeA.00750-16","journal-title":"Genome Announc"},{"key":"6706_CR38","doi-asserted-by":"publisher","first-page":"7239347","DOI":"10.1155\/2019\/7239347","volume":"2019","author":"MR Montecillo-Aguado","year":"2019","unstructured":"Montecillo-Aguado MR, Montes-G\u00f3mez AE, Garc\u00eda-Cordero J et al (2019) Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population. J Immunol Res 2019:7239347. https:\/\/doi.org\/10.1155\/2019\/7239347","journal-title":"J Immunol Res"},{"key":"6706_CR39","doi-asserted-by":"publisher","unstructured":"Castro-Jim\u00e9nez TK, G\u00f3mez-Legorreta LC, L\u00f3pez-Campa LA et al (2022) Variability in susceptibility to type I interferon response and subgenomic RNA accumulation between clinical isolates of dengue and Zika virus from Oaxaca Mexico correlate with replication efficiency in human cells and disease severity. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.890750","DOI":"10.3389\/fcimb.2022.890750"},{"key":"6706_CR40","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.mex.2018.05.011","volume":"5","author":"LS Toni","year":"2018","unstructured":"Toni LS, Garcia AM, Jeffrey DA et al (2018) Optimization of phenol-chloroform RNA extraction. MethodsX 5:599\u2013608. https:\/\/doi.org\/10.1016\/j.mex.2018.05.011","journal-title":"MethodsX"},{"key":"6706_CR41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/77553","volume":"6","author":"S-JL Wu","year":"2000","unstructured":"Wu S-JL, Grouard-Vogel G, Sun W et al (2000) Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6:816\u2013820. https:\/\/doi.org\/10.1038\/77553","journal-title":"Nat Med"},{"key":"6706_CR42","doi-asserted-by":"publisher","unstructured":"Eder J, Zijlstra-Willems E, Koen G et al (2023) Transmission of Zika virus by dendritic cell subsets in skin and vaginal mucosa. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1125565","DOI":"10.3389\/fimmu.2023.1125565"},{"key":"6706_CR43","doi-asserted-by":"publisher","unstructured":"Salom\u00e3o NG, Ara\u00fajo L, de Souza LJ et al (2025) Chikungunya virus infection in the skin: histopathology and cutaneous immunological response. Front Microbiol 16. https:\/\/doi.org\/10.3389\/fmicb.2025.1497354","DOI":"10.3389\/fmicb.2025.1497354"},{"key":"6706_CR44","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.meegid.2011.06.009","volume":"11","author":"P Surasombatpattana","year":"2011","unstructured":"Surasombatpattana P, Hamel R, Patramool S et al (2011) Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect Genet Evol 11:1664\u20131673. https:\/\/doi.org\/10.1016\/j.meegid.2011.06.009","journal-title":"Infect Genet Evol"},{"key":"6706_CR45","doi-asserted-by":"publisher","first-page":"7435621","DOI":"10.1155\/2017\/7435621","volume":"2017","author":"I Colombo","year":"2017","unstructured":"Colombo I, Sangiovanni E, Maggio R et al (2017) HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory\/Repair Response of Human Keratinocytes. Mediat Inflamm 2017:7435621. https:\/\/doi.org\/10.1155\/2017\/7435621","journal-title":"Mediat Inflamm"},{"key":"6706_CR46","doi-asserted-by":"publisher","first-page":"100128","DOI":"10.1016\/j.xjidi.2022.100128","volume":"2","author":"AT Esterly","year":"2022","unstructured":"Esterly AT, Lloyd MG, Upadhyaya P et al (2022) A Human Skin Model for Assessing Arboviral Infections. JID Innovations 2:100128. https:\/\/doi.org\/10.1016\/j.xjidi.2022.100128","journal-title":"JID Innovations"},{"key":"6706_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.0959-9673.2005.00445.x","volume":"86","author":"AY Limon-Flores","year":"2005","unstructured":"Limon-Flores AY, Perez-Tapia M, Estrada-Garcia I et al (2005) Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol 86:323\u2013334. https:\/\/doi.org\/10.1111\/j.0959-9673.2005.00445.x","journal-title":"Int J Exp Pathol"},{"key":"6706_CR48","doi-asserted-by":"publisher","first-page":"110232","DOI":"10.1016\/j.intimp.2023.110232","volume":"119","author":"GJ Fernandez","year":"2023","unstructured":"Fernandez GJ, Ram\u00edrez-Mej\u00eda JM, Castillo JA, Urcuqui-Inchima S (2023) Vitamin D modulates expression of antimicrobial peptides and proinflammatory cytokines to restrict Zika virus infection in macrophages. Int Immunopharmacol 119:110232. https:\/\/doi.org\/10.1016\/j.intimp.2023.110232","journal-title":"Int Immunopharmacol"},{"key":"6706_CR49","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fimmu.2018.00722","volume":"9","author":"M He","year":"2018","unstructured":"He M, Zhang H, Li Y et al (2018) Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway. Front Immunol 9:722. https:\/\/doi.org\/10.3389\/fimmu.2018.00722","journal-title":"Front Immunol"},{"key":"6706_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00705-024-06050-2","volume":"169","author":"LJ Hern\u00e1ndez-Sarmiento","year":"2024","unstructured":"Hern\u00e1ndez-Sarmiento LJ, Vald\u00e9s-L\u00f3pez JF, Urcuqui-Inchima S (2024) Zika virus infection suppresses CYP24A1 and CAMP expression in human monocytes. Arch Virol 169:135. https:\/\/doi.org\/10.1007\/s00705-024-06050-2","journal-title":"Arch Virol"},{"key":"6706_CR51","doi-asserted-by":"publisher","first-page":"105855","DOI":"10.1016\/j.antiviral.2024.105855","volume":"225","author":"C Wang","year":"2024","unstructured":"Wang C, Li M, Xia X et al (2024) Construction of exosome-loaded LL-37 and its protection against zika virus infection. Antiviral Res 225:105855. https:\/\/doi.org\/10.1016\/j.antiviral.2024.105855","journal-title":"Antiviral Res"},{"key":"6706_CR52","doi-asserted-by":"publisher","first-page":"e35866","DOI":"10.1371\/journal.pone.0035866","volume":"7","author":"AG Drannik","year":"2012","unstructured":"Drannik AG, Nag K, Yao X-D et al (2012) Trappin-2\/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:C. PLoS ONE 7:e35866. https:\/\/doi.org\/10.1371\/journal.pone.0035866","journal-title":"PLoS ONE"},{"key":"6706_CR53","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1128\/JVI.06561-11","volume":"86","author":"AG Drannik","year":"2012","unstructured":"Drannik AG, Nag K, Yao X-D et al (2012) Anti-HIV-1 activity of elafin is more potent than its precursor\u2019s, trappin-2, in genital epithelial cells. J Virol 86:4599\u20134610. https:\/\/doi.org\/10.1128\/JVI.06561-11","journal-title":"J Virol"},{"key":"6706_CR54","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1046\/j.1365-2133.2000.03766.x","volume":"143","author":"N Tanaka","year":"2000","unstructured":"Tanaka N, Fujioka A, Tajima S et al (2000) Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1\u03b2 and tumour necrosis factor\u2010\u03b1 stimulate its secretion in vitro. Br J Dermatol 143:728\u2013732. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03766.x","journal-title":"Br J Dermatol"},{"key":"6706_CR55","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1242\/jcs.107.8.2335","volume":"107","author":"JAC Alkemade","year":"1994","unstructured":"Alkemade JAC, Molhuizen HOF, Ponec M et al (1994) SKALP\/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci 107:2335\u20132342. https:\/\/doi.org\/10.1242\/jcs.107.8.2335","journal-title":"J Cell Sci"},{"key":"6706_CR56","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/oxfordjournals.jbchem.a124357","volume":"115","author":"K Nara","year":"1994","unstructured":"Nara K, Ito S, Ito T et al (1994) Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed cementoin. J Biochem 115:441\u2013448. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a124357","journal-title":"J Biochem"},{"key":"6706_CR57","doi-asserted-by":"publisher","first-page":"1671738","DOI":"10.3389\/fcimb.2025.1671738","volume":"15","author":"A Roth","year":"2025","unstructured":"Roth A, L\u00fctke S, M\u00f6rgelin M et al (2025) Vitamin D-inducible antimicrobial peptide LL-37 binds SARS-CoV-2 Spike and accessory proteins ORF7a and ORF8. Front Cell Infect Microbiol 15:1671738. https:\/\/doi.org\/10.3389\/fcimb.2025.1671738","journal-title":"Front Cell Infect Microbiol"},{"key":"6706_CR58","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s12539-021-00462-3","volume":"13","author":"D Li","year":"2021","unstructured":"Li D, Chen P, Shi T et al (2021) HD5 and LL-37 Inhibit SARS-CoV and SARS-CoV-2 Binding to Human ACE2 by Molecular Simulation. Interdiscip Sci 13:766\u2013777. https:\/\/doi.org\/10.1007\/s12539-021-00462-3","journal-title":"Interdiscip Sci"},{"key":"6706_CR59","doi-asserted-by":"publisher","first-page":"22417","DOI":"10.1074\/jbc.M710415200","volume":"283","author":"S Kota","year":"2008","unstructured":"Kota S, Sabbah A, Chang TH et al (2008) Role of Human \u03b2-Defensin-2 during Tumor Necrosis Factor-\u03b1\/NF-\u03baB-mediated Innate Antiviral Response against Human Respiratory Syncytial Virus*. J Biol Chem 283:22417\u201322429. https:\/\/doi.org\/10.1074\/jbc.M710415200","journal-title":"J Biol Chem"},{"key":"6706_CR60","doi-asserted-by":"publisher","first-page":"34730","DOI":"10.1074\/jbc.M604844200","volume":"281","author":"MW Butler","year":"2006","unstructured":"Butler MW, Robertson I, Greene CM et al (2006) Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway. J Biol Chem 281:34730\u201334735. https:\/\/doi.org\/10.1074\/jbc.M604844200","journal-title":"J Biol Chem"},{"key":"6706_CR61","first-page":"e3","volume":"7","author":"RJ Bick","year":"2007","unstructured":"Bick RJ, Poindexter BJ, Buja LM et al (2007) Nuclear Localization of HBD-1 in Human Keratinocytes. J Burns Wounds 7:e3","journal-title":"J Burns Wounds"},{"key":"6706_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/humrep\/dei276","volume":"21","author":"B Chen","year":"2006","unstructured":"Chen B, Wen Y, Zhang Z et al (2006) Microarray analysis of differentially expressed genes in vaginal tissues from women with stress urinary incontinence compared with asymptomatic women. Hum Reprod 21:22\u201329. https:\/\/doi.org\/10.1093\/humrep\/dei276","journal-title":"Hum Reprod"},{"key":"6706_CR63","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/bcr3374","volume":"15","author":"KK Hunt","year":"2013","unstructured":"Hunt KK, Wingate H, Yokota T et al (2013) Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Res 15:R3. https:\/\/doi.org\/10.1186\/bcr3374","journal-title":"Breast Cancer Res"},{"key":"6706_CR64","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2340\/00015555-2621","volume":"97","author":"H Kim","year":"2017","unstructured":"Kim H, Noh M, Bae O-N et al (2017) Pre-elafin is Involved in Ultraviolet-induced Keratinocyte Apoptosis via Pro-caspase-3 Activation Associated with Cystatin-A Downregulation. Acta Dermato-Venereologica 97:578\u2013585. https:\/\/doi.org\/10.2340\/00015555-2621","journal-title":"Acta Dermato-Venereologica"},{"key":"6706_CR65","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/1471-2407-8-290","volume":"8","author":"M Wenghoefer","year":"2008","unstructured":"Wenghoefer M, Pantelis A, Dommisch H et al (2008) Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer 8:290. https:\/\/doi.org\/10.1186\/1471-2407-8-290","journal-title":"BMC Cancer"},{"key":"6706_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ymthe.2021.08.007","volume":"30","author":"S Kheir","year":"2022","unstructured":"Kheir S, Villeret B, Garcia-Verdugo I, Sallenave J-M (2022) IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections. Mol Ther 30:355\u2013369. https:\/\/doi.org\/10.1016\/j.ymthe.2021.08.007","journal-title":"Mol Ther"},{"key":"6706_CR67","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1084\/jem.20050768","volume":"202","author":"CC Taggart","year":"2005","unstructured":"Taggart CC, Cryan S-A, Weldon S et al (2005) Secretory leucoprotease inhibitor binds to NF-\u03baB binding sites in monocytes and inhibits p65 binding. J Exp Med 202:1659\u20131668. https:\/\/doi.org\/10.1084\/jem.20050768","journal-title":"J Exp Med"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-026-06706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-026-06706-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-026-06706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:48:17Z","timestamp":1788857297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-026-06706-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6706"],"URL":"https:\/\/doi.org\/10.1007\/s00705-026-06706-1","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"244"}}